Business Standard

Astrazeneca Pharma India Share Price

Know More
BSENSE

5,252.70 24.15 (0.46%)

04:01 PM,24th Apr 2024

5,284.80 39.35 (0.75%)

03:53 PM,24th Apr 2024

BSE : 506820

NSE : ASTRAZEN

Sector : Health care

ISIN Code : INE203A01020

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 24-Apr-2024 | 04:01 PM IST

Market Cap (₹ Cr)

13,132

Turnover (₹ Cr)

0.01

Volume (Shares)

277

Face Value

2

52-WK High

7,208.00

52-WK High Date

06-Feb-2024

52-WK Low

3,118.55

52-WK Low Date

25-Apr-2023

All Time High

7,208.00

All Time High Date

06-Feb-2024

All Time Low

3.75

All Time Low Date

16-Jul-1990

Astrazeneca Pharma India Ltd

AstraZeneca Pharma India (APIL) was incorporated on July 11 1979. The Company is engaged in the business of manufacture distribution and marketing of pharmaceutical products and co-ordinates clinical trial services with an overseas group company. The major therapy areas where the company operates are Onocology Alimentary & Metabolism Cardio Vascular Renal Diabetes Respiratory and Oncology.AstraZeneca Pharma India formerly known as Astra-IDL (AIL) was an erstwhile joint venture of Astra Zeneca UK and Hinduja controlled IDL. Astra Pharmaceuticals AB Sweden acquired all of the 1287500 equity shares in the Company of IDL representing 25.75% of the Company's issued and paid up equity share capita...
Read More

Astrazeneca Phar Announcement

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>ASTRAZENECA PHARMA INDIA LTD.</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24231KA1979PLC003563</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>000</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Manasa R <br/> Designation: Company Secretary <br/> EmailId: manasa.r1@astrazeneca.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Bhavana Agrawal <br/> Designation: Chief Financial Officer and Director <br/> EmailId: bhavana.agrawal@astrazeneca.com</div> </div> <div> <br/> Date: 19/04/2024<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>

View More

Astrazeneca Pharma India Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

13,212

EPS - TTM (₹) [S]

63.80

P/E Ratio (X) [S]

20.17

Face Value (₹) 2
Latest Dividend (%)800.00
Latest Dividend Date 14-Jul-2023
Dividend Yield (%) 0.30
Book Value Share (₹) [S]261.99
P/B Ratio (₹) [S]20.17

Funds Owing this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
Nippon India Small Cap Fund (G) 347.14 6,51,493 0.76
Nippon India Small Cap Fund (B) 347.14 6,51,493 0.76
Nippon India Small Cap Fund - Direct (B) 347.14 6,51,493 0.76
Nippon India Small Cap Fund - Direct (G) 347.14 6,51,493 0.76
ICICI Pru P.H.D Fund - Direct (IDCW) 60.71 1,13,932 1.61
ICICI Pru P.H.D Fund - Direct (G) 60.71 1,13,932 1.61
ICICI Pru P.H.D Fund (G) 60.71 1,13,932 1.61
ICICI Pru P.H.D Fund (IDCW) 60.71 1,13,932 1.61
ICICI Pru Innovation Fund - Regular (G) 41.31 77,518 0.93
ICICI Pru Innovation Fund - Regular (IDCW) 41.31 77,518 0.93

Load more

Research Reports

Date Broker Action Prices(₹) Report
Data Not Found

Stock Strength

Today's Low/High

5,245.00

5,324.15

Week Low/High

5,130.50

5,330.00

Month Low/High

5,018.05

5,596.00

Year Low/High

3,098.00

7,221.00

All time Low/High

3.75

7,221.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-0.07%-0.01%1.251.15%
1 Month3.00%3.01%1.401.38%
3 Month-17.51%-17.58%3.934.42%
6 Month15.14%15.38%14.3716.18%
1 Year67.76%68.09%22.9726.26%
3 Year25.03%24.81%54.2556.21%

Company Info

Company Information

Chairman & Independent Directo : Narayan K Seshadri

Non-Exec. & Independent Dir. : Revathy Ashok

Whole Time Director & CFO : Rajesh Marwaha.

Non Executive Director : Weiying Sarah Wang

Non Executive Director : Ankush Nandra

Non-Exec. & Independent Dir. : Shilpa Divekar Nirula

Managing Director : Sanjeev Panchal

Non Executive Director : Hooi Bien Chuah

Registered Office: Blk N1 12th Flr Manyata Embass, Rachenahalli Outer Ring Road,Bangalore,Karnataka-560045 Ph: 91-080-67748000

Email:comp.secy@astrazeneca.com

URL:http://www.astrazeneca.in